<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d216">
    <sentence id="DDI-MedLine.d216.s0" text="Exposure to oral S-ketamine is unaffected by itraconazole but greatly increased by ticlopidine.&#xd;&#xa;">
        <entity id="DDI-MedLine.d216.s0.e0" charOffset="17-26"
            type="drug" text="S-ketamine"/>
        <entity id="DDI-MedLine.d216.s0.e1" charOffset="45-56"
            type="drug" text="itraconazole"/>
        <entity id="DDI-MedLine.d216.s0.e2" charOffset="83-93"
            type="drug" text="ticlopidine"/>
        <pair id="DDI-MedLine.d216.s0.p0" e1="DDI-MedLine.d216.s0.e0"
            e2="DDI-MedLine.d216.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d216.s0.p1" e1="DDI-MedLine.d216.s0.e0"
            e2="DDI-MedLine.d216.s0.e2" ddi="true" type="effect"/>
        <pair id="DDI-MedLine.d216.s0.p2" e1="DDI-MedLine.d216.s0.e1"
            e2="DDI-MedLine.d216.s0.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d216.s1" text="This study examined drug-drug interactions of oral S-ketamine with the cytochrome P450 (CYP) 2B6 inhibitor ticlopidine and the CYP3A inhibitor itraconazole. ">
        <entity id="DDI-MedLine.d216.s1.e0" charOffset="51-60"
            type="drug" text="S-ketamine"/>
        <entity id="DDI-MedLine.d216.s1.e1" charOffset="107-117"
            type="drug" text="ticlopidine"/>
        <entity id="DDI-MedLine.d216.s1.e2" charOffset="143-154"
            type="drug" text="itraconazole"/>
        <pair id="DDI-MedLine.d216.s1.p0" e1="DDI-MedLine.d216.s1.e0"
            e2="DDI-MedLine.d216.s1.e1" ddi="false"/>
        <pair id="DDI-MedLine.d216.s1.p1" e1="DDI-MedLine.d216.s1.e0"
            e2="DDI-MedLine.d216.s1.e2" ddi="false"/>
        <pair id="DDI-MedLine.d216.s1.p2" e1="DDI-MedLine.d216.s1.e1"
            e2="DDI-MedLine.d216.s1.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d216.s2" text="In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg S-ketamine after pretreatments with oral ticlopidine (250 mg twice daily), itraconazole (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks. ">
        <entity id="DDI-MedLine.d216.s2.e0" charOffset="87-96"
            type="drug" text="S-ketamine"/>
        <entity id="DDI-MedLine.d216.s2.e1" charOffset="128-138"
            type="drug" text="ticlopidine"/>
        <entity id="DDI-MedLine.d216.s2.e2" charOffset="162-173"
            type="drug" text="itraconazole"/>
        <pair id="DDI-MedLine.d216.s2.p0" e1="DDI-MedLine.d216.s2.e0"
            e2="DDI-MedLine.d216.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d216.s2.p1" e1="DDI-MedLine.d216.s2.e0"
            e2="DDI-MedLine.d216.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d216.s2.p2" e1="DDI-MedLine.d216.s2.e1"
            e2="DDI-MedLine.d216.s2.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d216.s3" text="Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas itraconazole treatment did not increase the exposure to S-ketamine. ">
        <entity id="DDI-MedLine.d216.s3.e0" charOffset="0-10"
            type="drug" text="Ticlopidine"/>
        <entity id="DDI-MedLine.d216.s3.e1" charOffset="134-141"
            type="drug" text="ketamine"/>
        <entity id="DDI-MedLine.d216.s3.e2" charOffset="164-175"
            type="drug" text="itraconazole"/>
        <entity id="DDI-MedLine.d216.s3.e3" charOffset="220-229"
            type="drug" text="S-ketamine"/>
        <pair id="DDI-MedLine.d216.s3.p0" e1="DDI-MedLine.d216.s3.e0"
            e2="DDI-MedLine.d216.s3.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-MedLine.d216.s3.p1" e1="DDI-MedLine.d216.s3.e0"
            e2="DDI-MedLine.d216.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d216.s3.p2" e1="DDI-MedLine.d216.s3.e0"
            e2="DDI-MedLine.d216.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d216.s3.p3" e1="DDI-MedLine.d216.s3.e1"
            e2="DDI-MedLine.d216.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d216.s3.p4" e1="DDI-MedLine.d216.s3.e1"
            e2="DDI-MedLine.d216.s3.e3" ddi="false"/>
        <pair id="DDI-MedLine.d216.s3.p5" e1="DDI-MedLine.d216.s3.e2"
            e2="DDI-MedLine.d216.s3.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d216.s4" text="The ratio of norketamine AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the ticlopidine (P &amp;lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo. ">
        <entity id="DDI-MedLine.d216.s4.e0" charOffset="13-23"
            type="drug_n" text="norketamine"/>
        <entity id="DDI-MedLine.d216.s4.e1" charOffset="39-46"
            type="drug" text="ketamine"/>
        <entity id="DDI-MedLine.d216.s4.e2" charOffset="94-104"
            type="drug" text="ticlopidine"/>
        <entity id="DDI-MedLine.d216.s4.e3" charOffset="125-136"
            type="drug" text="itraconazole"/>
        <pair id="DDI-MedLine.d216.s4.p0" e1="DDI-MedLine.d216.s4.e0"
            e2="DDI-MedLine.d216.s4.e1" ddi="false"/>
        <pair id="DDI-MedLine.d216.s4.p1" e1="DDI-MedLine.d216.s4.e0"
            e2="DDI-MedLine.d216.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d216.s4.p2" e1="DDI-MedLine.d216.s4.e0"
            e2="DDI-MedLine.d216.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d216.s4.p3" e1="DDI-MedLine.d216.s4.e1"
            e2="DDI-MedLine.d216.s4.e2" ddi="false"/>
        <pair id="DDI-MedLine.d216.s4.p4" e1="DDI-MedLine.d216.s4.e1"
            e2="DDI-MedLine.d216.s4.e3" ddi="false"/>
        <pair id="DDI-MedLine.d216.s4.p5" e1="DDI-MedLine.d216.s4.e2"
            e2="DDI-MedLine.d216.s4.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d216.s5" text="In the ticlopidine and itraconazole phases, the areas under the effect-time curves (self-reported drowsiness and performance) were significantly higher than those in the placebo phase (P &lt; 0.05). ">
        <entity id="DDI-MedLine.d216.s5.e0" charOffset="7-17"
            type="drug" text="ticlopidine"/>
        <entity id="DDI-MedLine.d216.s5.e1" charOffset="23-34"
            type="drug" text="itraconazole"/>
        <pair id="DDI-MedLine.d216.s5.p0" e1="DDI-MedLine.d216.s5.e0"
            e2="DDI-MedLine.d216.s5.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d216.s6" text="The findings suggest that the dosage of S-ketamine should be reduced in patients receiving ticlopidine.">
        <entity id="DDI-MedLine.d216.s6.e0" charOffset="40-49"
            type="drug" text="S-ketamine"/>
        <entity id="DDI-MedLine.d216.s6.e1" charOffset="91-101"
            type="drug" text="ticlopidine"/>
        <pair id="DDI-MedLine.d216.s6.p0" e1="DDI-MedLine.d216.s6.e0"
            e2="DDI-MedLine.d216.s6.e1" ddi="true" type="advise"/>
    </sentence>
</document>
